What is the diagnosis and recommended management for a patient with a short PR interval and possible delta‑wave morphology on ECG?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnosis and Management of Short PR Interval with Possible Delta Wave

The most likely diagnosis is Wolff-Parkinson-White (WPW) syndrome, characterized by an accessory pathway causing ventricular pre-excitation, and management depends critically on whether the patient is symptomatic and the pathway's conduction properties—symptomatic patients or those with high-risk features should undergo catheter ablation, while asymptomatic patients require risk stratification.

Diagnostic Confirmation

The ECG findings of a short PR interval (<120 ms) with a delta wave (slurred upstroke of the QRS complex) and QRS widening (>120 ms) are pathognomonic for ventricular pre-excitation 1. However, you must distinguish true WPW from benign mimics, particularly fasciculoventricular pathways (FVPs), which appear similar on surface ECG but carry no arrhythmic risk and should never be ablated 2.

Key Diagnostic Steps:

  • Electrophysiology study is essential to confirm the diagnosis and characterize the accessory pathway 3, 4
  • During EP study, a fixed His-ventricular interval across multiple pacing maneuvers indicates a benign FVP rather than a true accessory pathway 2
  • True accessory pathways show variable His-ventricular intervals and participate in tachycardia circuits

Risk Stratification

The critical concern is sudden cardiac death (SCD) risk, which occurs when atrial fibrillation conducts rapidly down the accessory pathway, degenerating into ventricular fibrillation 3, 5. The 10-year SCD risk ranges from 0.15% to 0.24%, with highest risk in the first two decades of life 3.

High-Risk Features:

  • History of symptomatic tachycardia (palpitations, syncope)
  • Shortest pre-excited R-R interval <250 ms during atrial fibrillation
  • Multiple accessory pathways
  • Young age (highest risk in first 20 years) 3

Management Algorithm

For Symptomatic Patients:

Catheter ablation is the definitive treatment with high success rates and should be performed for any symptomatic patient with documented AVRT or concerning features 3, 6.

For Asymptomatic Patients:

This remains controversial 4. If EP study demonstrates rapid antegrade conduction capability (shortest pre-excited R-R <250 ms), immediate radiofrequency ablation is recommended even in asymptomatic patients to prevent SCD 6. If the pathway shows slow conduction properties, observation with patient education about avoiding AV nodal blockers may be reasonable.

Acute Arrhythmia Management

If the patient presents with orthodromic AVRT (narrow complex tachycardia):

  1. Vagal maneuvers first (Valsalva, carotid massage) 3
  2. Adenosine 6-12 mg IV if vagal maneuvers fail 3
  3. Synchronized cardioversion if hemodynamically unstable or medications fail 3

Critical Pitfall:

If the patient presents with pre-excited atrial fibrillation (irregular wide complex tachycardia with variable QRS morphology):

  • NEVER use AV nodal blocking agents (adenosine, beta-blockers, calcium channel blockers, digoxin) as these can accelerate conduction down the accessory pathway and precipitate ventricular fibrillation 3
  • Immediate synchronized cardioversion if hemodynamically unstable 3
  • Ibutilide or IV procainamide if hemodynamically stable 3

Special Considerations

Unusual delta wave morphology (fractionated appearance) may indicate an epicardial accessory pathway, such as through a middle cardiac vein diverticulum, which requires specialized ablation techniques 5. Standard endocardial ablation may fail in these cases.

In pregnancy, management becomes more complex as pregnancy is arrhythmogenic 7. Acute episodes should be managed with vagal maneuvers and adenosine (safe in pregnancy), with cardioversion if necessary. Definitive ablation decisions should balance maternal and fetal risks.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.